Price
$32.59-0.94%Social Signal Score
Analyst Ratings
6 analystsRevenue
$257.48M+2.16%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Travis S. Dalton
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- Employees
- 3,000
- Beta
- 0.79
- Country
- US
- Piotroski score
- 5 / 9 (Middling)
- Altman Z-score
- -0.44
Financials
Revenue
$257.48M+2.2%Net Income
$-59.23MEBITDA
$201.97M+7.5%Free Cash Flow
$54.59M-58.0%EPS (diluted)
$-3.49Shares Outstanding (diluted)
16.96M-38.3%Operating Expenses
$55.39MCash & Debt
$14.37MReturn of Capital
$3.50MRevenue by Segment (annual)
$206.69MQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $965.41M | $-284.28M | $-17.30 |
| 2024 | $930.62M | $-1.65B | $-101.92 |
| 2023 | $961.52M | $-91.70M | $-5.69 |
| 2022 | $1.08B | $-572.91M | $-35.87 |
| 2021 | $1.12B | $102.08M | $6.40 |
| 2020 | $937.76M | $-520.56M | $-44.23 |
| 2019 | $982.90M | $9.71M | $0.35 |
| 2018 | $1.04B | $36.22M | $1.32 |
Valuation
CTEVhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
20-87.50%Social Signal Score
Mentions (3)
- Newsgurufocus.com·18d ago·Negative
Claritev Corp (CTEV) Stock Down 5.5% but Still Overvalued -- GF Score: 63/100 On September 17, 2026, Claritev Corp (CTEV) shares fell 5.5%, bringing the current price to $31.73. The stock has experienced a significant decline, with a rang
View source ↗ - Newsmarketbeat.com·59d ago·Neutral
Claritev Q2 Earnings Call Highlights Claritev NYSE: CTEV reported second-quarter revenue growth, record bookings and higher cash flow, prompting the healthcare technology company to raise its full-year revenue, adjusted EBITDA and free-cash-flow outlook.
View source ↗ - Newsseekingalpha.com·59d ago·Positive
Claritev Corporation (CTEV) Q2 2026 Earnings Call Transcript Claritev Corporation (CTEV) Q2 2026 Earnings Call Transcript
View source ↗
Earnings
Fri, Nov 6(in 4 weeks)
Consensus estimate $-3.63 per share
Typical surprise -35.6% (median, so one quarter with a near-zero estimate can't distort it)
- Fri, Aug 7$-3.49 vs $-4.12beat
- Thu, May 7$-4.41 vs $-3.81miss
- Mon, Feb 23$-4.88 vs $0.85miss
- Fri, Nov 7$-4.23 vs $-3.12miss
- Wed, Aug 6$-3.81 vs $-2.69miss
- Thu, May 8$-4.38 vs $-2.20miss
Estimates and results for CTEV via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by CTEV officers and directors.
- Bought
- $4.1m
- Sold
- $73.9m
25 trades
10 trades
- Garis Douglas Michaelsold
- Garis Douglas Michaelsold
- Dalton Travisbought
- Dalton Travisbought
- Misencik Tiffanisold
- Mintz William B.sold
- Carol Nutterbought
- Prince John Michaelbought
65 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
No disclosed congressional trades in CTEV.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.